Download these slides from an expert-led program on the role of biomarker testing and practical application of recently approved targeted therapies in NSCLC.
In this on-demand webcast from a live program, expert Beth Sandy, MSN, CRNP, discusses the importance of biomarker testing in NSCLC and approved targeted therapies for actionable genomic alterations.
Download this treatment summary reference guide for a review of updates in targeted therapies for NSCLC.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.